Finding of no Significant Impact for Genetically Engineered Atlantic Salmon (AquAdvantage Salmon)
This Notice document was issued by the Food and Drug Administration (FDA)
For related information, Open Docket Folder
| || |
Comment Period Closed
Apr 26 2013, at 11:59 PM ET
Show More Details
Date Posted: Dec 27, 2012
RIN: Not Assigned
LabelGMOs comments Part 5 of 8 3) FDA Process: The Draft EA and the Preliminary FONSI both appear to fail, as the FDA comment web site is very unclear as to...
U.S. Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 Docket No. FDA-2011-N-0899-0003 To Whom it May Concern: I am writing to...
LabelGMOs comments Part 8 of 8 6) it appears that U.S. Fish and Wildlife Service has already received requests to import AquAdvantage Salmon eggs into the U.S...
This document is contained in
Related Dockets: None
Related RINs: None
* This count refers to the total comment/submissions received on this document, as of 11:59 PM yesterday. Note: Agencies review all submissions, however some agencies may choose to redact, or withhold, certain submissions (or portions thereof) such as those containing private or proprietary information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. This can result in discrepancies between this count and those displayed when conducting searches on the Public Submission document type. For specific information about an agency’s public submission policy, refer to its website or the Federal Register document.